Annemie Ribbens

Poster(s):

• Th181 - Safety and Feasibility of Intradermal and Intranodal Administration of Vitamin d3-tolerogenic Dendritic Cells in Two Coordinated Phase I Clinical Trials in Active Multiple Sclerosis Patients
  Thursday, June 22, 2023

  7:30 AM – 7:30 PM